APOE and Alzheimer disease: Therefore, identifying genetic factors that interact with APOE ε4 genotype to reduce Aβ burden and, eventually, a participant’s risk for developing AD, may inspire novel strategies for preventing or halting the progression of AD and reveal novel targets for effective therapeutic interventions.